Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: GroupAssignment: SGLT2 inhibitors vs. GLP-1 RA - JSON Representation

Raw json | Download

{
  "resourceType" : "EvidenceVariable",
  "id" : "236950",
  "meta" : {
    "versionId" : "63",
    "lastUpdated" : "2024-10-03T13:11:20.368Z",
    "profile" : [
      🔗 "http://hl7.org/fhir/uv/ebm/StructureDefinition/group-assignment"
    ]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: EvidenceVariable 236950</b></p><a name=\"236950\"> </a><a name=\"hc236950\"> </a><a name=\"236950-en-US\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">version: 63; Last updated: 2024-10-03 13:11:20+0000</p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-group-assignment.html\">GroupAssignment</a></p></div><p><b>url</b>: <a href=\"https://fevir.net/resources/EvidenceVariable/236950\">https://fevir.net/resources/EvidenceVariable/236950</a></p><p><b>identifier</b>: FEvIR Object Identifier/236950, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-group-assignment-85394-85798</p><p><b>name</b>: GroupAssignment_SGLT2_inhibitors_vs_GLP_1_RA</p><p><b>title</b>: GroupAssignment: SGLT2 inhibitors vs. GLP-1 RA</p><p><b>status</b>: Active</p><p><b>publisher</b>: Computable Publishing LLC</p><p><b>contact</b>: <a href=\"mailto:support@computablepublishing.com\">support@computablepublishing.com</a></p><p><b>description</b>: </p><div><p>This EvidenceVariable Resource is referenced in an example for the EBMonFHIR Implementation Guide.</p>\n</div><p><b>copyright</b>: </p><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>\n</div><p><b>author</b>: Computable Publishing®: MAGIC-to-FEvIR Converter: </p><h3>RelatedArtifacts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>ResourceReference</b></td></tr><tr><td style=\"display: none\">*</td><td>Part Of</td><td>MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes (Identifier: FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-conversion-report)</td></tr></table><h3>Definitions</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 defined-in-handling-and-category}\">Defined in handling and category elements</span></td></tr></table><p><b>handling</b>: dichotomous variable</p><blockquote><p><b>category</b></p><p><b>name</b>: SGLT2 inhibitors</p><p><b>value</b>: <a href=\"Group-236769.html\">Sodium-Glucose Transport Protein 2 (SGLT2) inhibitors</a></p></blockquote><blockquote><p><b>category</b></p><p><b>name</b>: GLP-1 RA</p><p><b>value</b>: <a href=\"Group-236776.html\">Glucagon-Like Peptide-1 (GLP-1) receptor agonists</a></p></blockquote></div>"
  },
  "url" : "https://fevir.net/resources/EvidenceVariable/236950",
  "identifier" : [
    {
      "type" : {
        "coding" : [
          {
            "system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code" : "ACSN",
            "display" : "Accession ID"
          }
        ],
        "text" : "FEvIR Object Identifier"
      },
      "system" : "https://fevir.net",
      "value" : "236950",
      "assigner" : {
        "display" : "Computable Publishing LLC"
      }
    },
    {
      "type" : {
        "text" : "FEvIR Linking Identifier"
      },
      "system" : "https://fevir.net/FLI",
      "value" : "MAGIC-5288-j1Wqrn-group-assignment-85394-85798",
      "assigner" : {
        "display" : "Computable Publishing LLC"
      }
    }
  ],
  "name" : "GroupAssignment_SGLT2_inhibitors_vs_GLP_1_RA",
  "title" : "GroupAssignment: SGLT2 inhibitors vs. GLP-1 RA",
  "status" : "active",
  "publisher" : "Computable Publishing LLC",
  "contact" : [
    {
      "telecom" : [
        {
          "system" : "email",
          "value" : "support@computablepublishing.com"
        }
      ]
    }
  ],
  "description" : "This EvidenceVariable Resource is referenced in an example for the EBMonFHIR Implementation Guide.",
  "copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/",
  "author" : [
    {
      "name" : "Computable Publishing®: MAGIC-to-FEvIR Converter"
    }
  ],
  "relatedArtifact" : [
    {
      "type" : "part-of",
      "resourceReference" : {
        "type" : "Composition",
        "identifier" : {
          "type" : {
            "text" : "FEvIR Linking Identifier"
          },
          "system" : "https://fevir.net/FLI",
          "value" : "MAGIC-5288-j1Wqrn-conversion-report",
          "assigner" : {
            "display" : "Computable Publishing LLC"
          }
        },
        "display" : "MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes"
      }
    }
  ],
  "definition" : {
    "concept" : {
      "coding" : [
        {
          "system" : "https://fevir.net/resources/CodeSystem/179423",
          "code" : "defined-in-handling-and-category",
          "display" : "Defined in handling and category elements"
        }
      ]
    }
  },
  "handling" : "dichotomous",
  "category" : [
    {
      "name" : "SGLT2 inhibitors",
      "valueReference" : {
        🔗 "reference" : "Group/236769",
        "type" : "Group",
        "identifier" : {
          "type" : {
            "text" : "FEvIR Linking Identifier"
          },
          "system" : "https://fevir.net/FLI",
          "value" : "MAGIC-5288-j1Wqrn-intervention-85394-I-85798",
          "assigner" : {
            "display" : "Computable Publishing LLC"
          }
        },
        "display" : "Sodium-Glucose Transport Protein 2 (SGLT2) inhibitors"
      }
    },
    {
      "name" : "GLP-1 RA",
      "valueReference" : {
        🔗 "reference" : "Group/236776",
        "type" : "Group",
        "identifier" : {
          "type" : {
            "text" : "FEvIR Linking Identifier"
          },
          "system" : "https://fevir.net/FLI",
          "value" : "MAGIC-5288-j1Wqrn-comparator-85394-C-85798",
          "assigner" : {
            "display" : "Computable Publishing LLC"
          }
        },
        "display" : "Glucagon-Like Peptide-1 (GLP-1) receptor agonists"
      }
    }
  ]
}